Express Pharma - Express Pharma

Biopharma Shakti programme to boost domestic manufacturing of biologics and biosimilars. The Budget also announces customs duty…

How have pharma companies changed the way they plan and choose real estate after the pandemic? What matters most to them now,…

The pharmaceutical facility landscape has become increasingly complex. Regulatory expectations, operational efficiency,…

Why is localising format part production an important step for Indian pharmaceutical companies and Romaco? Sanjeev Nimkar: It…

PFAS has moved from a technical concern to a leadership agenda item. For food brands, exporters, packaging suppliers, and testing…

PFAS in water testing is unforgiving: target lists vary by matrix, action levels are low, and background contamination can creep…

PFAS testing gets complicated fast, not because the science is impossible, but because the details matter. Targets vary by matrix,…

Union Ministry of Health and Family Welfare has notified key amendments to the New Drugs and Clinical Trials (NDCT) Rules, 2019 to…

Dr Vikas Jain, Superspecialist Robotic Joint Replacement and Sports Medicine Surgeon, CARE CHL hospital, Indore As a knee…

Clinical trial procurement is moving from a narrow, transactional "buying" function to a strategic capability that shapes speed,…